Subtype
Tenosynovial Giant Cell Tumor
CI-CAN-00001563TGCTExplore in graph →
Non-malignant9 active trials
- NCIt
- C3402
- DOID
- 314
- MeSH
- D000070779
Loading cancer entity…
Subtype
CI-CAN-00001563TGCTExplore in graph →
Clinical trials
25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04938180 | A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | terminated | Phase 2 | 4 | AmMax Bio, Inc.INDUSTRY | 3 | May 24, 2024 | clinicaltrials |
Data updated 23 days agoSource updated May 24, 2024source: clinicaltrials